Stemline Therapeutics Inc.

(STML)

By |

Profile

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

Contact Information

Website: www.stemline.com
Main Phone: +1 646 502-2311
Address: 750 Lexington Avenue
Address 2: 11th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10022

Issuer Information

Exchange: NSC
Employees: 24
NAICS: Biological Produ
$ 13.50 ($ 0.65) (-4.59%)
Last Price 13.50 Change $ -0.65 Change % -4.59 Tick N/A
Bid 13.00 Bid Size 300.00 Ask N/A Ask Size 0.00
Open 14.15 High 14.60 Low 13.35 Prev Close 14.15
Last Trade Volume 195,613 52 Wk Hi 14.60 52 Wk Low 3.88
Market Cap 258.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,158,732.00 EPS (TTM) -2.17 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 14
Number of Buys 0 4
Number of Sells 0 10
Net Activity 0 148795
Last 10 Buys Shares
Ivan Bergstein 1,000
Kenneth J. Zuerblis 1,000
Kenneth Hoberman 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
J. Kevin Buchi 1,000
Last 10 Sell Shares
Kenneth Hoberman 1,000
David G. Gionco 1,000
Ivan Bergstein 1,000
Kenneth Hoberman 1,000
Ivan Bergstein 1,000
David G. Gionco 1,000
David G. Gionco 1,000
Ivan Bergstein 1,000
Eric K. Rowinsky 1,000
Kenneth Hoberman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 41 41 41 41
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 29.8 29.8 29.8 29.8
Standard Deviation 10.76 10.76 10.76 10.76
Date of Most Recent Estimate 08/09/16 08/05/16 06/07/16 08/09/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1